Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2023-04-27 Director's Dealing
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice - TSH 3 pages 234.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including the number of shares and options acquired, disposed, and held before and after the change. The document is a formal notification of insider share transactions by a company director. It does not contain financial statements, earnings data, or management discussion. The content matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 4165 characters, consistent with a detailed insider trading notice rather than a full financial report or announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2023-04-27 English
OSX Successfully transitions to EU Medical Device Regulation 2 pages 247.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX release announcing Osteopore Limited's successful transition to the new European Union Medical Device Regulation (MDR). It highlights regulatory compliance achievements and market opportunities but does not contain financial statements, detailed financial performance data, or comprehensive report content. The document is a regulatory announcement about compliance status and business continuity rather than a full financial report or detailed management discussion. It is not an annual or interim report, earnings release, or investor presentation. Given the nature of the content as a regulatory compliance update and business announcement, the most appropriate classification is Regulatory Filings (RNS). The document length (4741 characters) and content support this classification with high confidence.
2023-04-26 English
Top 20 and Distribution List - Options 4 pages 19.2KB
Major Shareholding Notification Classification · 95% confidence The document is titled 'TOP 20 INVESTORS REPORT' and lists detailed information about the largest shareholders and their holdings in Osteopore Limited as of April 24, 2023. It includes ranks, investor names, balances, and percentage of issued capital. There is no financial performance data, management discussion, or regulatory compliance content. The document is a shareholder ownership report, which aligns with notifications about major shareholdings or significant share ownership levels. Therefore, the document fits best under the category 'Major Shareholding Notification' (MRQ). The document length is 4319 characters, which is sufficient to contain substantive data rather than a brief announcement. Hence, it is not a report publication announcement or regulatory filing. Confidence is high due to the clear content and format.
2023-04-25 English
Reinstatement of Security Class to Quotation 1 page
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX regarding the reinstatement of a security class to quotation. It is a brief notice about the lifting of suspension of options for Osteopore Limited, referencing compliance with a listing rule. The document is short (679 characters) and serves as an official regulatory announcement rather than a detailed financial report or other specific filing type. It does not contain financial statements, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and compliance notices.
2023-04-25 English
Non-Renounceable Entitlement Offer - Results 2 pages 241.4KB
Capital/Financing Update Classification · 100% confidence The document is an ASX release announcing the results of a non-renounceable entitlement offer, detailing the amount raised, the subscription terms, and the next steps for placing the shortfall securities. It focuses on capital raising activities and shareholder subscription details. There are no financial statements or comprehensive financial performance data presented, nor is it a report or presentation. The content clearly relates to financing and capital structure update. The document length is short (3136 characters), and it is not an announcement of a report publication but a direct update on financing activity. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-04-23 English
Security Class Suspension from Quotation 1 page 425
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX Limited regarding the suspension of a security class (OSXO) from quotation. It is a regulatory announcement about trading status and compliance under a listing rule, not a financial report, management change, or other specific filing type. The document is short and focused on a regulatory compliance action related to stock listing status, which fits best under Regulatory Filings (RNS).
2023-04-23 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.